CIDRAP newsletters options
Also, NIAID Director Fauci says speeding a vaccine through trials is not compromising safety.
Underlying conditions place 22% of people at increased risk for severe COVID-19 and 4% at high risk.
Of the total, 3.8 million COVID-19 cases have been reported in the Americas, where the pandemic is accelerating.
Unpublished data from a large randomized controlled trial in the United Kingdom indicate that dexamethasone, a cheap, widely available steroid, reduces deaths in hospitalized COVID-19 patients requiring respiratory support.
Data on passengers on the Diamond Princess reflect differences between symptomatic and symptomatic cases.
"What I'm afraid I see happening is people are kind of over it. This is old news; we're going to move on."
About 1 in 15 US parents (6.1%) is hesitant about childhood vaccines, while 1 in 4 (26%) are unsure about flu vaccines.
The agency says the drugs "are unlikely to be effective in treating COVID-19 for the authorized uses."
For the past 2 weeks, more than 100,000 new global cases have been reported almost every day.
Officials reported five more illnesses and three more deaths in a new Ebola outbreak in the Democratic Republic of the Congo (DRC), according to figures reported today by the country's multisectoral Ebola response committee (CMRE).
The new developments raise the outbreak total to 17 cases, 14 of them confirmed and 3 listed as probable. The new deaths raise the fatality count to 11.
An investigation by Chinese and US scientists of a cluster of COVID-19 infections in China provides evidence that the coronavirus can spread through casual contacts at social gatherings.
Pandemic disruptions in some nations are affecting pregnant women, and lockdowns reduce access to mental health services, nutrition for young people.
Redfield said Americans need to embrace CDC recommendations.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A new study in The Lancet shows that the population prevalence of antibodies to SARS-CoV2, the virus that causes COVID-19, grew in Geneva, Switzerland, in April from 5% to 11%.
A meta-analysis of randomized controlled trials and observational studies found that extended infusion of antipseudomonal beta-lactam antibiotics in critically ill patients who had respiratory infections was associated with reduced mortality but not with clinical success, Japanese and Egyptian researchers reported yesterday in the International Journal of Infectious Diseases.
Also, the NIH said researchers will begin assessing antiviral and anti-inflammatory drugs in children.
Though Latin America remains the world's main hot spot, cases are also rising in Africa and the Mideast.
Experts say states need to re-emphasize safety measures that can slow the spread of the virus.
A study of children hospitalized for community-acquired pneumonia (CAP) found that a shorter course of antibiotics did not increase the odds of treatment failure compared with a longer course, US researchers reported today in the Journal of the Pediatric Infectious Diseases Society.
